Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
First Phase III Depression Data For Intra-Cellular’s Caplyta Exceed Expectations
Add-On To Schizophrenia, Bipolar Depression Indications
Apr 17 2024
•
By
Mandy Jackson
Lumateperone met the primary and secondary endpoints in MDD • Source: Shutterstock
More from Clinical Trials
More from R&D